Elective cosmetic procedures

1010 WINS Newsroom
October 23, 2019 - 12:30 pm
WASHINGTON (AP) — U.S. health officials want women getting breast implants to receive stronger warnings and more details about the possible risks and complications. The Food and Drug Administration said Wednesday that manufacturers should add a warning highlighted by a box — the most serious type...
Read More
In this June 5, 2009, photo a woman has Botox injected at Reveal in Arlington, Va. AbbVie is buying Botox maker Allergan in a cash-and-stock deal the drugmakers value at around $63 billion. The maker of the blockbuster immune disorder treatment Humira said Tuesday, June 25, 2019, that it will pay $120.30 in cash and a portion of AbbVie stock for each Allergan share. (AP Photo/Jacquelyn Martin, File)
June 25, 2019 - 2:39 pm
Facing competition for the world's top-selling drug, AbbVie is jumping on this year's pharmaceutical merger bandwagon with a $63 billion bid for Botox maker Allergan that's meant to spur future growth. Specialty drugmaker AbbVie said Tuesday that adding Allergan's aesthetics products and eye care...
Read More
FILE - This Thursday, Aug. 2, 2018, file photo shows the U.S. Food and Drug Administration building behind FDA logos at a bus stop on the agency’s campus in Silver Spring, Md. The FDA said Thursday, May 2, 2019, that a type of breast implant linked to a rare form of cancer will be allowed to stay on the market. (AP Photo/Jacquelyn Martin, File)
May 02, 2019 - 6:14 pm
WASHINGTON (AP) — U.S. health authorities will allow a type of breast implant linked to a rare form of cancer to stay on the market, saying its risks do not warrant a national ban. But the Food and Drug Administration said Thursday it is considering bold warnings for the implants and requiring...
Read More
FILE - This Dec. 11, 2006 file photo shows a silicone gel breast implant in Irving, Texas. U.S. health officials are taking another look at the safety of breast implants, the latest review in a decades-long debate. At a two-day meeting that starts Monday, March 25, 2019, a panel of experts for the U.S. Food and Drug Administration will hear from researchers, plastic surgeons and implant makers, as well as from women who believe their ailments were caused by the implants. (AP Photo/Donna McWilliam, File)
March 24, 2019 - 8:28 am
WASHINGTON (AP) — U.S. health officials are taking another look at the safety of breast implants, the latest review in a decades-long debate. At a two-day meeting that starts Monday, a panel of experts for the U.S. Food and Drug Administration will hear from researchers, plastic surgeons and...
Read More
FILE - This Dec. 11, 2006 file photo shows a silicone gel breast implant at a manufacturing facility in Irving, Texas. On Friday, Sept. 14, 2018, U.S. health officials said they will convene a public meeting of medical advisers in 2019 on the safety of breast implants because of growing science on the topic, including an independent analysis that suggests certain rare health problems might be more common in women with implants containing silicone gel. (AP Photo/Donna McWilliam, File)
September 14, 2018 - 3:24 pm
U.S. health regulators say they'll convene a public meeting of medical advisers next year to discuss new science on breast implant safety, including an independent analysis that suggests certain rare health problems might be more common with silicone gel implants. The Food and Drug Administration...
Read More